Direkt zum Inhalt

Owner only: item control page
Wilhelmi, Tim ; Xu, Xingbo ; Tan, Xiaoying ; Hulshoff, Melanie S. ; Maamari, Sabine ; Sossalla, Samuel ; Zeisberg, Michael ; Zeisberg, Elisabeth M.

Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1

Wilhelmi, Tim, Xu, Xingbo, Tan, Xiaoying, Hulshoff, Melanie S., Maamari, Sabine, Sossalla, Samuel, Zeisberg, Michael and Zeisberg, Elisabeth M. (2020) Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1. Theranostics 10 (9), pp. 3905-3924.

Date of publication of this fulltext: 11 Oct 2021 13:06
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleTheranostics
Publisher:IVYSPRING INT PUBL
Place of Publication:LAKE HAVEN
Volume:10
Number of Issue or Book Chapter:9
Page Range:pp. 3905-3924
Date2020
InstitutionsMedicine > Lehrstuhl für Innere Medizin II
Identification Number
ValueType
10.7150/thno.38640DOI
KeywordsTRANSFORMING GROWTH FACTOR-BETA(1); PRESSURE-OVERLOAD; DOUBLE-BLIND; RELAXIN; FIBROBLASTS; MECHANISM; FAILURE; HORMONE; NOTCH; DIFFERENTIATION; Serelaxin; EndMT; fibrosis; Notch; histone methylation
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID50498

Export bibliographical data

Owner only: item control page

nach oben